Comet Diagnostics announcement, the company received a notice of equity changes issued by shareholders Shanghai Peixi and its concerted action person HJ CAPITAL on September 3. From January 12, 2023 to September 2, 2024, Shanghai Peixi and its concerted action person collectively reduced their shares in the company by 4,040,104 shares, accounting for 1.01% of the total share capital. Before this equity change, Shanghai Peixi and its concerted action person collectively held 39,224,454 shares of the company, accounting for 9.78% of the total share capital. After the change, they collectively hold 35,184,350 shares of the company, accounting for 8.77% of the total share capital. This equity change will not result in a change of the company's controlling shareholder or actual controller.